A 59-year-old man diagnosed with borderline lepromatous leprosy developed reddish patches and plaques on the face, which progressively enlarged and spread to the trunk and limbs ([Figure 1A](#F1){ref-type="fig"}--[D](#F1){ref-type="fig"} Figure 1.Pre-therapy clinical photograph showing reddish patches and plaques appeared on the patient's face (**A**), elbow (**B**), knee (**C**), and buttock (**D**).). Other superficial nerves appeared normal. Biopsy showed plasmocytic and lymphocytic infiltration in the nerve tract, and was 4+ acid-fast bacilli (AFB)--stain positive suggesting *Mycobacterium leprae* ([Figure 2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"} Figure 2.Pre-therapy histopathologic analysis showing (left leg): (**A**) plasmocytic and lymphocytic infiltration surrounding dermal nerve and Schwann cells and inflammatory cell infiltrated into nerve tract (Hematoxylin and Eeosin \[H&E\] staining ×400), and (**B**) positive staining for lepra bacilli (4+) (acid-fast bacilli \[AFB\] stain).); this was confirmed by real-time polymerase chain reaction (PCR). The HLA-B\*13:01 test was negative. Two weeks after rifampin, dapsone, and clofazimine (World Health Organization multidrug therapy \[WHO MDT\] regimen) were started, the skin lesions (hypochromic macules) became red, edematous, and enlarged ([Figure 3A](#F3){ref-type="fig"}--[D](#F3){ref-type="fig"} Figure 3.Post-therapy clinical photograph (2 weeks after initiation of multidrug therapy \[MDT\]). The preexisting lesions in the form of hypochromic macules turned red, edematous, squamous, enlarged, and the inflammatory infiltration aggravated, face (**A**), knee (**B**), elbow (**C**), and buttock (**D**).). Both ulnar nerves became tender and thickened; ultrasonography showed reduction of blood flow ([Figure 4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"} Figure 4.Post-therapy (2 weeks after initiation of multidrug therapy \[MDT\]) ultrasonography and color Doppler images of peripheral nerve of the patient. (**A**) Cross-section scan of the right side ulnar nerve with hypoechoic fascicles: 0.889 cm at its widest point and (**B**) abnormal blood flow signals around the right ulnar nerve.). Collectively these findings indicated a type 1 conversion reaction (T1R) ([Figure 2C](#F2){ref-type="fig"}). One year after prednisone was started (40 mg/day for 3 months with progressive tapering), the T1R was found to be completely resolved.

In leprosy, type 1 and type 2 reactions---whether spontaneous or related to treatment---are the main causes of morbidity. T1Rs result from cell-mediated immunity affecting up to 30% of susceptible individuals.[@R1] Nonpolar forms of leprosy are the primary risk factor for the occurrence of T1Rs.[@R2] Systemic corticosteroids remain the mainstay of treatment of T1Rs.
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